StockData
aTYR PHARMA INC logo

aTYR PHARMA INC (ATYR) stock

ATYRNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 5/30
$4.08−0.91 (-18.24%)

Close on Nov 18, 2026Market cap $400.20MP/E –Yield –

aTYR PHARMA price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

aTYR PHARMA's price to sales ratio was 10.4× on Apr 30, 2026, against 281.5× a year earlier. Over the last 3 years it ranged from 3.5× to 495.2×, with a median of 8.7×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Apr 30, 202610.4×+0.3
2025Dec 31, 202510.1×−392.1
2024Oct 31, 2024402.2×+394.5
2023Dec 29, 20237.7×+3.4
2021Apr 30, 20214.3×−0.3
2020Dec 31, 20204.5×–

More aTYR PHARMA figures

See a number that looks wrong?